AXIN1 Gene: Axis Inhibition Protein 1

Key regulator of the Wnt/β-catenin signaling pathway and tumor suppressor

Gene Information Card

Symbol AXIN1
Full Name Axis Inhibition Protein 1
Gene Type Protein coding
Chromosomal Location 16p13.3
NCBI Gene ID 8312 ncbi.nlm.nih.gov/gene/8312
Ensembl ID ENSG00000103197
UniProt ID O15169
OMIM ID 603816
HGNC ID 903
Aliases AXIN, PPP1R49, MGC5232

Description

AXIN1 (Axis Inhibition Protein 1) is a tumor suppressor gene that encodes a key scaffold protein in the Wnt/β-catenin signaling pathway. It negatively regulates the pathway by facilitating the phosphorylation and degradation of β-catenin via the destruction complex. Loss-of-function mutations in AXIN1 lead to constitutive Wnt signaling and are frequently observed in hepatocellular carcinoma and other cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hepatocellular carcinoma Loss-of-function mutations impair β-catenin degradation, leading to nuclear accumulation and transcriptional activation of Wnt target genes. ClinVar, COSMIC
Colorectal cancer AXIN1 mutations contribute to Wnt pathway activation, often in tumors without APC mutations. COSMIC, NCBI
Medulloblastoma Somatic AXIN1 mutations are found in a subset of WNT-subtype medulloblastomas. COSMIC, OMIM
Hepatoblastoma AXIN1 mutations are associated with β-catenin stabilization and tumorigenesis. ClinVar, COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 8.2 Medium
Colon 6.5 Medium
Brain 5.1 Low
Kidney 4.8 Low
Lung 3.9 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 12.3 Hepatocellular carcinoma cell line
HEK293 9.7 Embryonic kidney cells
HCT116 8.1 Colorectal carcinoma cell line
MCF7 6.4 Breast cancer cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1975C>T (p.Arg659*) Nonsense 2.5% in HCC Loss of function; truncation of C-terminal domain
c.2140_2141del (p.Leu714fs) Frameshift 1.8% in HCC Loss of function; premature termination
c.1660G>A (p.Gly554Ser) Missense 0.5% in colorectal cancer Likely loss of function; disrupts β-catenin binding
c.1A>G (p.Met1?) Start loss Rare Loss of function; no protein translation
Mutation functional classification

Loss of Function (LOF)

Most AXIN1 mutations are loss-of-function, leading to impaired β-catenin degradation and constitutive Wnt signaling.

Gain of Function (GOF)

No gain-of-function mutations are reported for AXIN1.

Dominant Negative (DN)

Some truncating mutations may exert dominant-negative effects by interfering with wild-type AXIN1 in the destruction complex.

Gene Ontology (GO)

protein binding (GO:0005515) cytoplasm (GO:0005737)
Wnt signaling pathway (GO:0016055) β-catenin destruction complex (GO:0030879)
• transcription regulatory region DNA binding (GO:0044212)

Pathways

Wnt/β-catenin signaling pathway (KEGG: hsa04310)
Hepatocellular carcinoma pathway (KEGG: hsa05225)
Colorectal cancer pathway (KEGG: hsa05210)

Protein Summary

AXIN1 is a 862-amino acid scaffold protein that forms the core of the β-catenin destruction complex, along with APC, GSK3B, and CK1. It contains domains for binding β-catenin, GSK3B, and itself (dimerization). The protein is essential for regulating cytoplasmic β-catenin levels; loss of AXIN1 function results in β-catenin stabilization and activation of Wnt target genes, promoting oncogenesis.

Related Products

Product name Cat.No. Species Gene ID
AXIN1 Knockout HEK293 Cell Line EDJ-KQ278 Human 8312 Details Get a Quote
AXIN1 Knockout HCT 116 Cell Line EDJ-KQ17961 Human 8312 Details Get a Quote
AXIN1 Knockout HeLa Cell Line EDJ-KQ18336 Human 8312 Details Get a Quote
AXIN1 Knockout A-549 Cell Line EDJ-KQ18383 Human 8312 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: